PR Newswire
NEW YORK
,
May 30, 2022
/PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB). Such investors are advised to contact
Robert S. Willoughby
at
[email protected]
or 888-476-6529, ext. 7980.
The investigation concerns whether Enochian and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On
May 25, 2022
, the U.S. Department of Justice announced that Serhat Gumrukcu, the co-founder of Enochian, had been arrested and charged in a murder-for-hire conspiracy.
On this news, Enochian’s stock price fell
$2.17
per share, or 36.97%, to close at
$3.70
per share on
May 25, 2022
.
Pomerantz LLP, with offices in
New York
,
Chicago
,
Los Angeles
,
Paris
, and
Tel Aviv
, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late
Abraham L. Pomerantz
, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See
www.pomlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980
View original content to download multimedia:
https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-enochian-biosciences-inc—enob-301557400.html
SOURCE Pomerantz LLP
